NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Free Cash Flow Generation Index
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $29.08 Million represents 1% of operating cash flow ($29.19 Million). Explore NewAmsterdam Pharma Company N.V. Ordinar (NAMS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NewAmsterdam Pharma Company N.V. Ordinary Shares Free Cash Flow Generation Index (2022–2022)
Historical FCF Generation Index trend for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. For the full cash flow conversion analysis, see NAMS cash flow metrics.
Annual Free Cash Flow Generation for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year Free Cash Flow Generation Index for NewAmsterdam Pharma Company N.V. Ordinary Shares. Check NewAmsterdam Pharma Company N.V. Ordinar (NAMS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.98x | $10.44 Million | $10.66 Million | $221.00K | — |